NASDAQ:TTOO

T2 Biosystems SEC Filings & 10K Form

$1.22
-0.07 (-5.43 %)
(As of 06/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.21
$1.29
50-Day Range
$1.04
$1.47
52-Week Range
$1.01
$3.79
Volume2.98 million shs
Average Volume9.07 million shs
Market Capitalization$183.13 million
P/E RatioN/A
Dividend YieldN/A
Beta0.25

T2 Biosystems (NASDAQ:TTOO) SEC Filings

DateFilerForm TypeView
06/11/2021
8:18 AM
T2 Biosystems (Filer)
Form DEFA14A
06/01/2021
3:00 PM
T2 Biosystems (Filer)
Form SD
Specialized Disclosure Report  
05/25/2021
3:06 PM
T2 Biosystems (Filer)
Form DEFA14A
05/14/2021
9:45 AM
T2 Biosystems (Filer)
Form DEFA14A
05/14/2021
9:42 AM
T2 Biosystems (Filer)
Form DEF 14A
05/13/2021
1:52 PM
T2 Biosystems (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2021
3:16 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
3:24 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2021
11:15 PM
T2 Biosystems (Filer)
Form EFFECT
03/31/2021
3:30 PM
T2 Biosystems (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/19/2021
8:44 AM
Sperzel John J III (Reporting)
T2 Biosystems (Issuer)
Form 4/A
03/18/2021
3:34 PM
Barclay Alec (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
3:34 PM
Pare Anthony (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
11:41 AM
Pare Anthony (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
11:41 AM
Barclay Alec (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
3:23 PM
Sprague John M (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
3:23 PM
Gibbs Michael Terrence (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
1:23 PM
Gibbs Michael Terrence (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
1:19 PM
Sprague John M (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
1:14 PM
Barclay Alec (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:37 PM
GOLDMAN SACHS & CO. LLC (Filed by)
T2 Biosystems (Subject)
Form SC 13G/A
01/19/2021
3:06 PM
Ahuja Aparna (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
1:59 PM
Ahuja Aparna (Reporting)
T2 Biosystems (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/05/2021
2:10 PM
Bernard Thierry (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
2:10 PM
LIEBMAN SEYMOUR (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
2:08 PM
Elsbree David B (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
2:08 PM
T2 Biosystems (Issuer)
Toft Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
2:06 PM
Saunders Ninfa (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
11:01 AM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2020
3:02 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2020
12:15 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2020
7:30 AM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2020
6:58 PM
McDonough John (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:51 PM
CUMMING JOHN W (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:42 PM
LIEBMAN SEYMOUR (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
5:10 PM
T2 Biosystems (Issuer)
Toft Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
5:09 PM
Saunders Ninfa (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
4:46 PM
Bernard Thierry (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
3:43 PM
Elsbree David B (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
7:31 AM
T2 Biosystems (Filer)
Form DEFA14A
07/14/2020
7:00 AM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
3:14 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2020
3:04 PM
T2 Biosystems (Filer)
Form DEFA14A
06/17/2020
8:00 AM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
3:23 PM
T2 Biosystems (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/22/2020
7:04 AM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
1:56 PM
T2 Biosystems (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2020
3:00 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2020
3:46 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2020
12:01 PM
Gibbs Michael Terrence (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2020
6:04 AM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
3:48 PM
Barclay Alec (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
3:46 PM
Lowery Thomas J. (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
3:46 PM
Pare Anthony (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
4:27 PM
T2 Biosystems (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2020
11:39 AM
Sprague John M (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
11:10 AM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2020
5:24 PM
Barclay Alec (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
5:22 PM
Gibbs Michael Terrence (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
5:19 PM
Lowery Thomas J. (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:35 PM
Lowery Thomas J. (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:31 PM
Gibbs Michael Terrence (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
1:49 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
T2 Biosystems (Subject)
Form SC 13G/A
02/05/2020
4:02 PM
Gibbs Michael Terrence (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
4:01 PM
McDonough John (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
4:01 PM
Lowery Thomas J. (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
1:09 PM
Pare Anthony (Reporting)
T2 Biosystems (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/27/2020
1:58 PM
McDonough John (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
9:28 AM
Sperzel John J III (Reporting)
T2 Biosystems (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2020
5:14 PM
McDonough John (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2020
3:47 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
3:46 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
1:12 PM
Elsbree David B (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
6:34 PM
GOLDMAN SACHS & CO. LLC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
6:14 PM
Jones Adrian M (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
12:55 PM
LIEBMAN SEYMOUR (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
12:49 PM
Elsbree David B (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
6:45 AM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
4:17 PM
T2 Biosystems (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2019
3:12 PM
T2 Biosystems (Filer)
Form NT 10-Q
11/13/2019
2:19 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2019
5:05 AM
Barclay Alec (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2019
4:32 PM
Sprague John M (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2019
4:25 PM
Gibbs Michael Terrence (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2019
4:23 PM
Lowery Thomas J. (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
3:35 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
3:00 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
4:20 PM
T2 Biosystems (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
3:32 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
3:43 PM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
3:05 PM
T2 Biosystems (Filer)
Form 424B5
07/30/2019
3:03 PM
T2 Biosystems (Filer)
Form 424B5
06/13/2019
3:31 PM
Cima Michael J. (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:30 PM
Lapidus Stanley (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:30 PM
CUMMING JOHN W (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:30 PM
Elsbree David B (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
6:06 PM
Jones Adrian M (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
10:16 AM
T2 Biosystems (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
5:23 PM
Lapidus Stanley (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:18 PM
Elsbree David B (Reporting)
T2 Biosystems (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 6/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.